Altiris Therapeutics - Atlanta, Georgia 30329

Altiris Therapeutics is categorized under Unclassified in Atlanta, GA .

Business Name: Altiris Therapeutics
Contact Person: Lawrence Wilson
Address: 1325 Briarvista Way Ne, Atlanta, Georgia 30329
Phone Number: (404) 537-4961
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Unclassified
SIC Code: 7389
NAICS Code: 561990
Share This Business:
Related Businesses: John B Agnew & Associates Inc - Atlanta, GA 30329
Lawerence Tommy - Atlanta, GA 30329
Pictacs Inc - Atlanta, GA 30329
Senoj LLC - Atlanta, GA 30329
James Bower - Atlanta, GA 30329
Koko Gallery LLC - Atlanta, GA 30329
Neenanikki Inc - Atlanta, GA 30329
Mcbrayer & Mcbrayer Inc - Atlanta, GA 30329
Picubed Inc - Atlanta, GA 30329
Slovin Advisors Inc - Atlanta, GA 30329
Martin V&G Inc - Atlanta, GA 30329
Techedge Inc - Atlanta, GA 30329
Freddyboymusic Inc - Atlanta, GA 30329
Lopez Arturo Ramirez - Atlanta, GA 30329
Susan R Bailey P C - Atlanta, GA 30329
Gwinnett Tech - Atlanta, GA 30329
Aaa Road Rescue Inc - Atlanta, GA 30329
Schel Inc - Atlanta, GA 30329
Edward Spitzberg LLC - Atlanta, GA 30329
Stone Mountain Highland Games Inc - Atlanta, GA 30329

The company Altiris Therapeutics provides B2B services in the form of Unclassified from its single location in Georgia. 1 to 4 employees work for Altiris Therapeutics, and the business now earns $100.000 to $499.999 per annum.

Altiris Therapeutics was launched in 2010 and is classified under SIC code and category 7389 , and NAICS number and grouping 561990 . To contact Altiris Therapeutics, please call Lawrence Wilson with the phone number (404) 537-4961 or visit its single location at 1325 Briarvista Way Ne in Atlanta, Georgia 30329.

The location of the single location can also be found using the coordinates 33.814255,-84.332163. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.